ArticleOncotarget2017

Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action.

Kuikui Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.